Overview

Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Hospitalized Adults With COVID-19

Status:
Recruiting

Trial end date:
2021-10-01

Target enrollment:

Participant gender:

Summary

This is a placebo-controlled study to investigate the safety and efficacy of a single injection of COVI-AMG in inpatient adults with COVID-19.

Phase:

Phase 2

Details

Lead Sponsor:

Sorrento Therapeutics, Inc.